19 December 2022Cannasouth enters prospective merger arrangement with EqalisCannasouth Limited (NZX:CBD) is pleased to announce that it has signed a binding term sheet (“Term Sheet”) with the Board of ...Read More
14 December 2022Helius first to gain THC certification in NZHelius Therapeutics will soon launch THC containing medicines that are both grown and made in New Zealand. Read more ...Read More
7 December 2022Helius achieves GACP CertificationHelius Therapeutics has received Good Agricultural and Collection Practice (GACP) certification at its purpose-built medicinal cannabis facility in East Tamaki, Auckland. ...Read More
3 December 2022Helius gains NZ’s first GMP certification for cannabis medicinesNew Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, has been issued with the industry’s first GMP (Good Manufacturing Practice) certificate ...Read More
24 November 2022Philip Brown appointed chairman of Greenfern IndustriesNew Plymouth businessman Philip Brown has been appointed chairman of NZX-listed medicinal cannabis company Greenfern Industries Limited. The role was vacated ...Read More
15 November 2022Rua Opens 2022 He Ara Atawhai – Undergraduate and Postgraduate ScholarshipsRua is now inviting specific East Coast kura to nominate students for our undergraduate scholarships as well as inviting all postgraduate ...Read More
15 November 2022Eqalis receives GMP certification to accelerate local production of medicinal cannabisLeading Bay of Plenty-based medicinal cannabis company Eqalis has successfully applied for and received its Good Manufacturing Practice (GMP) license, allowing ...Read More
26 October 2022Greenfern medicinal cannabis achieves stringent quality standardsGreenfern Industries is pleased to announce that recently received overseas lab testing results of their medicinal cannabis flower starting material has ...Read More
19 October 2022Rua Bioscience Confirms First International OrderRua Bioscience Limited (NZX: RUA) formally announced today that it has received its first order via its German distributor Nimbus Health, ...Read More
7 October 2022Significant Headway Made with Trans-Tasman Medicinal Cannabis PartnershipRua Bioscience’s cultivation partnership with Australian-based Cann Group is making significant headway; the two companies achieving key milestones this week. read ...Read More
15 September 2022New Zealand-grown cannabis-based medicine cuts cost for Kiwi patientsFor the first time in New Zealand, Kiwi patients can now be prescribed New Zealand-grown, New Zealand-made cannabis medicine. Read more ...Read More
15 September 2022NZ’s first locally grown cannabis medicines get approval“This is great news for many patients who have long sought legal access to both New Zealand-grown and made medicinal cannabis ...Read More